Trending Market News

The U.S. Food and Drug Administration has approved Sanofi's injection treatment for children aged 8 to 17 years recently diagnosed with stage 3 type 1 diabetes. The drug is designed to slow the loss of the body's natural insulin production in this patient population.

• The approval targets a specific pediatric age range of 8-17 years with recent stage 3 type 1 diabetes diagnosis
• The treatment aims to preserve the body's own insulin production rather than replace it
• This represents a new therapeutic option for managing early-stage type 1 diabetes in children

Exxon Mobil is set to appoint Alex Volkov as head of global trading, replacing Tracey Gunnlaugsson who is retiring after leading the division since 2023. The leadership change comes after Exxon reported a $3.9 billion derivatives loss in Q1 2025, its lowest net income in five years, contrasting sharply with profitable trading results from European oil rivals.

• Alex Volkov has nearly 30 years of experience at Exxon with roles across the US, Russia, and London; David Brown, an international crude trader, is also retiring
• Exxon's $3.9 billion paper loss from derivatives in Q1 pushed net income to a five-year low, underperforming European competitors
• European oil majors reported strong Q1 trading profits from the energy supply crunch triggered by the U.S.-Israeli war on Iran

The U.S. Centers for Medicare and Medicaid Services proposed a rule establishing a permanent framework for Medicare drug price negotiations beginning in 2029. The framework aims to reduce costs for millions of patients while offering pharmaceutical companies greater regulatory certainty regarding pricing negotiations.

• The proposed rule creates policies for negotiating and renegotiating prices specifically for costly, single-source drugs
• Implementation is scheduled to begin in 2029, providing a multi-year runway for stakeholders to prepare
• The framework balances patient cost reduction objectives with industry demands for more predictable negotiation processes

The U.S. Justice Department's Antitrust Division has approved Paramount Skydance Corp's planned $110 billion acquisition of Warner Bros Discovery, according to Politico citing sources familiar with the matter. This clearance removes a major regulatory hurdle for one of the largest media industry mergers in recent years.

• The $110 billion deal represents a massive consolidation in the entertainment and media sector
• DOJ antitrust approval suggests regulators do not see the combination as anticompetitive despite the size of both entities
• The merger would unite major film studios and streaming platforms under common ownership

The FDA has expanded approval of Dexcom's Stelo Glucose Biosensor System to children aged two and older who do not use insulin, making it the first over-the-counter continuous glucose monitor for pediatric use. The device was previously cleared for adults 18 and older in March 2024. This expansion allows children with diabetes and their caregivers to track glucose levels continuously without a prescription.

• Stelo uses a wearable sensor and smartphone app to display glucose readings and trends every 15 minutes, with each sensor lasting up to 15 days (potentially shorter in children)
• The device is approved only for patients who do not use insulin and is not designed to alert users about dangerously low blood sugar levels
• Children must use the device under adult supervision, and users should consult healthcare providers before changing medications based on its readings

Streaming platform Roku is in talks to sell itself, with Bloomberg News reporting that discussions include a possible media tie-up. The deliberations may not result in a transaction, and Roku has not commented on the report.

• Bloomberg cited people familiar with the matter as sources for the sale discussions
• A potential media tie-up is being considered as part of the sale talks
• There is no certainty the discussions will lead to an actual transaction

Elon Musk has become the world's first trillionaire following SpaceX's debut on the Nasdaq. His combined net worth from Tesla and SpaceX reached approximately $1.05 trillion as of Friday, with his SpaceX stake valued at $280 billion.

• SpaceX began trading on the Nasdaq, contributing $280 billion to Musk's total wealth
• Musk's net worth from both Tesla and SpaceX combined now totals roughly $1.05 trillion
• This milestone marks the first time any individual has achieved trillionaire status

Shell is preparing to sell its offshore wind farm assets for over $1 billion as part of CEO Wael Sawan's strategy to exit renewable energy investments. The sale, expected in 2027, marks the oil giant's continued shift away from low-carbon projects to focus on liquefied natural gas trading and upstream operations.

• Shell has hired Rothschild & Co and PJT Partners to lead the sale process, which is likely to occur in 2027
• The move aligns with CEO Wael Sawan's strategy to curb low-carbon projects and concentrate on LNG trading and upstream operations
• Shell is also reviewing strategic options for its India-based Sprng Energy renewable power unit as part of its broader renewables exit

Exxon Mobil is exploring potential acquisitions including Australia's Woodside Energy Group, according to Bloomberg News. The move would strengthen Exxon's position in liquefied natural gas (LNG), which major energy companies view as a key growth area driven by rising power demand and gas consumption.

• Woodside Energy is among several acquisition targets Exxon has been evaluating, though both companies declined to comment or did not respond to requests
• An acquisition would bolster Exxon's LNG capabilities as the industry sees natural gas as critical for meeting growing global electricity demand
• The potential deal reflects broader consolidation trends in the energy sector as major oil companies seek to expand their gas portfolios

Embraer's electric aircraft subsidiary Eve announced it will manage spending cautiously as it targets 2028 certification for its electric vertical takeoff and landing (eVTOL) vehicle, having pushed back its timeline from an original 2026 target. The company believes its $441 million cash position from Q1 is sufficient to fund operations through 2028.

• Eve has $441 million in cash as of Q1 and expects to operate at the lower end of its $225-275 million cash consumption guidance for 2026
• Certification timeline has been delayed twice, moving from initial 2026 target to 2027, and now to 2028
• Brazil's aviation regulator ANAC considers the 2028 timeframe realistic based on successful test results to date

South Korean memory chipmaker SK Hynix plans to list on the Nasdaq exchange for its upcoming U.S. listing as early as this year, choosing the tech-focused bourse over the New York Stock Exchange. The decision aims to capitalize on investor appetite for AI-linked stocks, given SK Hynix's position as the world's second-largest memory chipmaker and key Nvidia supplier. The move is expected to raise the company's profile among global investors and could raise up to $14 billion.

• SK Hynix selected Nasdaq over NYSE, likely driven by the exchange's historically higher valuations for technology companies and larger passive fund flows into Nasdaq-listed tech stocks
• The company's stock has surged 230% recently, benefiting from its dominant position in high-bandwidth memory chips used in AI servers
• The U.S. SEC is expected to approve SK Hynix's American depositary receipt listing during the week of June 22, with the offering potentially raising up to $14 billion

AI executives from major companies including OpenAI, Google DeepMind, Anthropic, and Mistral AI will attend the G7 summit in France from June 15-17, 2026. The gathering will focus on AI governance, online safety, and the protection of minors online. Leaders from the G7 nations and the EU will hold discussions with tech executives on regulation, AI infrastructure, and broader technology issues.

• High-profile attendees include Sam Altman (OpenAI), Demis Hassabis (Google DeepMind), Dario Amodei (Anthropic), and Marc Benioff (Salesforce), among others from leading AI firms
• A declaration on the protection of minors online will be a key agenda item for G7 leaders at the summit in Evian-les-Bains
• Tech business leaders will meet with G7 officials at a working lunch on June 17 to discuss regulation, AI infrastructure and networks

New Federal Reserve Chair Kevin Warsh is signaling a major shift in Fed communications, potentially reducing the frequency of press conferences and forward guidance about interest rate decisions. Warsh has criticized current Fed communication practices for leading to policy errors and believes central banks speak too frequently. This approach represents a departure from predecessor Jerome Powell's practice of holding press conferences after every Fed meeting.

• Warsh has not committed to holding press conferences at every Fed meeting and previously recommended the Bank of England reduce meetings from 12 to 8 annually, calling monthly schedules 'sub-optimal'
• Three FOMC members dissented at the last meeting seeking removal of the 'easing bias' signaling rate cuts, which Warsh may address at his first meeting amid pressure from President Trump for lower rates
• Warsh criticizes the Fed's 'dot plot' forecasts for causing the Fed to hold onto projections too long, believing this prevented quick action on pandemic-era inflation

The SEC has delayed the launch of leveraged ETFs tied to SpaceX until Monday, preventing asset managers from trading these products on the company's IPO debut day on Friday. The delay affects major issuers including Direxion, Granite, and Tradr ETFs, who had sought to capitalize on anticipated first-day volatility in what is described as a record $75 billion IPO.

• Exchanges informed ETF issuers on Wednesday that listings must be pushed to the first trading day after the IPO, citing SEC concerns that leveraged products could complicate SpaceX's market debut
• Asset managers estimate these leveraged SpaceX ETF products could collectively hold more than $10 billion in assets, with billions at stake in the first few weeks of trading alone
• This marks an unprecedented situation, as leveraged single-stock ETFs have only been introduced in the U.S. within the past four years and have no prior history of launching alongside an underlying stock's IPO

Luxury stocks rallied sharply following a proposed U.S.-Iran peace deal that would reopen the Strait of Hormuz and lift U.S. oil sanctions on Iran, according to Iranian state media. Major luxury brands saw significant gains, with LVMH, Kering, and Hermes each rising approximately 5%. The luxury sector had been negatively impacted by the Iran war, as the Middle East represents a fast-growing market for these companies.

• LVMH, Kering (Gucci owner), and Hermes each gained about 5%, while Richemont rose 3.4% and the pan-European luxury index increased 1.8%
• The proposed deal includes reopening the Strait of Hormuz and lifting U.S. oil sanctions on Iran
• Luxury stocks had been heavily affected by the Iran conflict, with the Middle East being a fast-growing market for the otherwise muted sector

A proposed memorandum of understanding between Iran and the U.S. would lift oil sanctions on Iran in exchange for reopening the Strait of Hormuz, according to Iranian state media. The 14-point draft agreement stipulates that final negotiations cannot begin until the U.S. releases half of Iran's frozen funds, suspends oil sanctions, and lifts the naval blockade.

• The draft deal includes U.S. commitment to lift oil sanctions and Iran's commitment to reopen the Strait of Hormuz
• Preconditions for final negotiations include release of half of Iran's frozen funds, suspension of oil sanctions, and lifting of naval blockade
• The agreement is reported by Iranian state media (Mehr News Agency) and represents a potential major shift in U.S.-Iran relations affecting global oil markets

Three major European banks—Rabobank, ING, and Crédit Agricole—are reportedly interested in acquiring a stake in Belgium's state-owned Belfius bank. The Belgian government plans to sell a 20% stake via private placement, valuing the bank at approximately €10 billion ($11.56 billion), as it seeks to reduce debt and fund increased defense spending.

• Belgium's Finance Minister announced plans to sell 20% of Belfius through private placement, with the bank valued at around €10 billion
• Belfius management previously indicated preference for selling to domestic or foreign investors rather than to competing banks, though sale rules have not yet been finalized
• The state acquired Belfius in 2011 for €4 billion after purchasing the Belgian arm of Franco-Belgian lender Dexia during the financial crisis

Woodside Energy exercised its pre-emptive right to acquire a 10.67% stake in the Browse Joint Venture from PetroChina International Investment (Australia), blocking a potential deal with Japan's INPEX. The transaction is valued at $225 million plus reimbursement of cash call contributions made since June 30, 2025.

• Woodside will pay $225 million to PetroChina for the 10.67% stake in Browse JV
• The acquisition blocks a competing deal with Japan's INPEX through pre-emptive rights
• Additional costs include reimbursement of cash call contributions made by PetroChina since June 30, 2025

Nvidia has hired Bruce Andrews, a veteran lobbyist and former Intel government affairs chief, to lead its Washington, D.C. government affairs operations. Andrews previously served as Intel's top lobbyist under former CEO Pat Gelsinger and held a Commerce Department position during the Obama administration. The move signals Nvidia's intent to strengthen its regulatory and policy presence in the nation's capital.

• Andrews brings experience from both the private sector (Intel's government affairs chief) and government (Obama-era Commerce Department official)
• The hire comes as Nvidia faces increasing regulatory scrutiny amid its dominant position in AI chip manufacturing
• Nvidia declined to comment on the appointment when contacted by Reuters

Novartis announced positive results from an early-to-mid-stage trial of del-brax, an experimental drug acquired through its $12 billion acquisition, for treating facioscapulohumeral muscular dystrophy (FSHD). The drug lowered blood markers linked to the rare genetic muscle disorder and showed reduced signs of muscle damage, potentially becoming the first disease-modifying treatment for FSHD, which affects 45,000 to 87,000 people in the U.S. and EU.

• Del-brax demonstrated reduced blood markers associated with FSHD and showed decreased muscle damage in patients suffering from this progressive muscle weakness disorder
• The drug could become the first disease-modifying treatment for FSHD, a rare condition affecting approximately 45,000 to 87,000 people across the U.S. and EU
• Novartis plans to discuss trial data with global health regulators while a late-stage study is currently enrolling patients